These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20407935)

  • 41. Prognostic value of cancer stem cell marker CD133 expression in pancreatic ductal adenocarcinoma (PDAC): a systematic review and meta-analysis.
    Li X; Zhao H; Gu J; Zheng L
    Int J Clin Exp Pathol; 2015; 8(10):12084-92. PubMed ID: 26722393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
    Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
    Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Experimental investigation of CD133 as a putative marker of tumor-initiating cell in laryngeal carcinoma].
    Wei XD; Zhou L; Cheng L; Tian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Dec; 41(12):940-4. PubMed ID: 17345710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the expression of stem cell markers in human breast cancer reveals a correlation with clinical progression and metastatic disease in ductal carcinoma.
    Martin TA; Jiang WG
    Oncol Rep; 2014 Jan; 31(1):262-72. PubMed ID: 24173498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive value for lymph node metastasis of epithelial-mesenchymal transition and cancer stem cell marker expression in early gastric cancer.
    Nam KH; Yoon H; Lee K; Park DJ; Kim HH; Lee HS; Shin E
    Pathol Res Pract; 2017 Sep; 213(9):1221-1226. PubMed ID: 28595915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemical expression of cancer stem cell related markers CD44 and CD133 in endometrial cancer.
    Elbasateeny SS; Salem AA; Abdelsalam WA; Salem RA
    Pathol Res Pract; 2016 Jan; 212(1):10-6. PubMed ID: 26608413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients.
    Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A
    Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD44 is of functional importance for colorectal cancer stem cells.
    Du L; Wang H; He L; Zhang J; Ni B; Wang X; Jin H; Cahuzac N; Mehrpour M; Lu Y; Chen Q
    Clin Cancer Res; 2008 Nov; 14(21):6751-60. PubMed ID: 18980968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Visualization of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas: non-overlapping membrane expression in cell populations positive for both markers.
    Immervoll H; Hoem D; Steffensen OJ; Miletic H; Molven A
    J Histochem Cytochem; 2011 Apr; 59(4):441-55. PubMed ID: 21411814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bmi-1 is essential for the oncogenic potential in CD133(+) human laryngeal cancer cells.
    Wei X; He J; Wang J; Yang X; Ma B
    Tumour Biol; 2015 Nov; 36(11):8931-42. PubMed ID: 26081615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Investigation of CD133 as putative marker of tumor-initiating cell in laryngeal carcinoma].
    Wei XD; Zhou L; Cheng L; Tian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 42(9):692-6. PubMed ID: 18051573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma.
    Jiang S; Pei L; Yang ZL; Liu G
    Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry.
    Wu S; Yu L; Wang D; Zhou L; Cheng Z; Chai D; Ma L; Tao Y
    BMC Cancer; 2012 Nov; 12():535. PubMed ID: 23170850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD133, one of the markers of cancer stem cells in Hep-2 cell line.
    Zhou L; Wei X; Cheng L; Tian J; Jiang JJ
    Laryngoscope; 2007 Mar; 117(3):455-60. PubMed ID: 17334305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
    Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
    Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
    Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA
    Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
    Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
    Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The critical role of CD133(+)CD44(+/high) tumor cells in hematogenous metastasis of liver cancers.
    Hou Y; Zou Q; Ge R; Shen F; Wang Y
    Cell Res; 2012 Jan; 22(1):259-72. PubMed ID: 21862973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of cancer stem cell markers CD133 and CD44 in locoregional recurrence of rectal cancer.
    Nagata T; Sakakura C; Komiyama S; Miyashita A; Nishio M; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Ikoma H; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Otsuji E
    Anticancer Res; 2011 Feb; 31(2):495-500. PubMed ID: 21378329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD44+/CD24- cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast.
    Tiezzi DG; Valejo FA; Marana HR; Carrara HH; Benevides L; Antonio HM; Sicchieri RD; Milanezi CM; Silva JS; de Andrade JM
    Med Oncol; 2012 Sep; 29(3):1479-85. PubMed ID: 21713550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.